GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PixarBio Corp (GREY:PXRB) » Definitions » ROE % Adjusted to Book Value

PixarBio (PixarBio) ROE % Adjusted to Book Value : 0.00% (As of Sep. 2016)


View and export this data going back to 2016. Start your Free Trial

What is PixarBio ROE % Adjusted to Book Value?

PixarBio's ROE % for the quarter that ended in Sep. 2016 was -69.12%. PixarBio's PB Ratio for the quarter that ended in Sep. 2016 was N/A. PixarBio's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2016 was N/A.


PixarBio ROE % Adjusted to Book Value Historical Data

The historical data trend for PixarBio's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PixarBio ROE % Adjusted to Book Value Chart

PixarBio Annual Data
Trend Dec14 Dec15
ROE % Adjusted to Book Value
- -

PixarBio Quarterly Data
Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PixarBio's ROE % Adjusted to Book Value

For the Biotechnology subindustry, PixarBio's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PixarBio's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PixarBio's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where PixarBio's ROE % Adjusted to Book Value falls into.



PixarBio ROE % Adjusted to Book Value Calculation

PixarBio's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2015 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-30.30% / N/A
=N/A

PixarBio's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2016 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-69.12% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PixarBio ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of PixarBio's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


PixarBio (PixarBio) Business Description

Industry
Traded in Other Exchanges
N/A
Address
200 Boston Avenue, Suite 1875, Medford, MA, USA, 02155
PixarBio Corp is a specialty pharmaceutical company focused on preclinical and clinical commercial development of therapeutic drug delivery systems for post-operative pain. The company's lead clinical candidate, NeuroRelease is a non-opioid / non-opiate preclinical stage product intended for the treatment of surgical pain, with planned future indications for chronic pain. NeuroRelease blocks nociceptive and neuropathic pain signals arising from temperature and pressure stimuli without affecting motor function, which is intended to allow for effective treatment without delaying post-surgical physical therapy.

PixarBio (PixarBio) Headlines